Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.
Kramer J, Linker R, Paling D, Czaplinski A, Hoffmann O, Yong VW, Barker N, Ross AP, Lucassen E, Gufran M, Hu X, Zielman R, Seifer G, Vermersch P. Kramer J, et al. Among authors: zielman r. Mult Scler J Exp Transl Clin. 2023 Oct 10;9(4):20552173231203816. doi: 10.1177/20552173231203816. eCollection 2023 Oct-Dec. Mult Scler J Exp Transl Clin. 2023. PMID: 37829441 Free PMC article.
Cerebrospinal Fluid and Plasma Amine Profiles in Interictal Migraine.
Onderwater GLJ, van Dongen RM, Harms AC, Zielman R, van Oosterhout WPJ, van Klinken JB, Goeman JJ, Terwindt GM, van den Maagdenberg AMJM, Hankemeier T, Ferrari MD. Onderwater GLJ, et al. Among authors: zielman r. Ann Neurol. 2023 Apr;93(4):715-728. doi: 10.1002/ana.26576. Epub 2023 Jan 30. Ann Neurol. 2023. PMID: 36511835
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, Totolyan N, Pingili R, Mancione L, Hu X, Sullivan R, Su W, Zielman R, Gupta AD, Montalban X, Winthrop K. Cross AH, et al. Among authors: zielman r. Neurol Ther. 2022 Jun;11(2):759-762. doi: 10.1007/s40120-022-00346-8. Neurol Ther. 2022. PMID: 35503396 Free PMC article. No abstract available.
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.
Hauser SL, Cross AH, Winthrop K, Wiendl H, Nicholas J, Meuth SG, Giacomini PS, Saccà F, Mancione L, Zielman R, Bagger M, Das Gupta A, Häring DA, Jehl V, Kieseier BC, Pingili R, Stoneman D, Su W, Willi R, Kappos L. Hauser SL, et al. Among authors: zielman r. Mult Scler. 2022 Sep;28(10):1576-1590. doi: 10.1177/13524585221079731. Epub 2022 Mar 1. Mult Scler. 2022. PMID: 35229668 Free PMC article. Clinical Trial.
Cortical glutamate and gamma-aminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study.
Onderwater GLJ, Wijnen JP, Najac C, van Dongen RM, Ronen I, Webb A, Zielman R, van Zwet EW, Ferrari MD, Kan HE, Kruit MC, Terwindt GM. Onderwater GLJ, et al. Among authors: zielman r. Neuroimage Clin. 2021;32:102889. doi: 10.1016/j.nicl.2021.102889. Epub 2021 Nov 24. Neuroimage Clin. 2021. PMID: 34911195 Free PMC article.
30 results